Fermentable oligosaccharides, disaccharides, monosaccharides and polyols: role in irritable bowel syndrome
- PMID: 24830318
- DOI: 10.1586/17474124.2014.917956
Fermentable oligosaccharides, disaccharides, monosaccharides and polyols: role in irritable bowel syndrome
Abstract
Irritable bowel syndrome (IBS) was previously left poorly treated despite its high prevalence and cost. Over the past decade, significant research has been conducted providing new dietary strategies for IBS management. The 'low fermentable oligosaccharides, disaccharides, monosaccharides and polyols diet' has shown symptom improvement in 68-76% of patients. Randomized, controlled trials have now proven its efficacy. The diet, low in poorly absorbed and fermentable carbohydrates, uses dietary restriction and re-challenge to determine individual tolerance to various short-chain carbohydrates. However there may be potential detrimental effects of the diet in the long term, due to potential changes to the gastrointestinal microbiota. Appropriate dietary education and management of the diet is imperative. Future research should focus on the relevance of changes to the microbiota and ways to liberalize the dietary restrictions.
Keywords: FODMAP; abdominal pain; carbohydrates; diet therapy; gastrointestinal diseases; irritable bowel syndrome.
Similar articles
-
Extending our knowledge of fermentable, short-chain carbohydrates for managing gastrointestinal symptoms.Nutr Clin Pract. 2013 Jun;28(3):300-6. doi: 10.1177/0884533613485790. Epub 2013 Apr 24. Nutr Clin Pract. 2013. PMID: 23614962 Review.
-
Dietary Fermentable Oligosaccharides, Disaccharides, Monosaccharides, and Polyols (FODMAPs) and Gastrointestinal Disease.Nutr Clin Pract. 2018 Aug;33(4):468-475. doi: 10.1002/ncp.10108. Epub 2018 Jun 5. Nutr Clin Pract. 2018. PMID: 29870082 Review.
-
History of the low FODMAP diet.J Gastroenterol Hepatol. 2017 Mar;32 Suppl 1:5-7. doi: 10.1111/jgh.13685. J Gastroenterol Hepatol. 2017. PMID: 28244673 Review.
-
A diet low in FODMAPs reduces symptoms of irritable bowel syndrome.Gastroenterology. 2014 Jan;146(1):67-75.e5. doi: 10.1053/j.gastro.2013.09.046. Epub 2013 Sep 25. Gastroenterology. 2014. PMID: 24076059 Clinical Trial.
-
Fecal Fermentation in Irritable Bowel Syndrome: Influence of Dietary Restriction of Fermentable Oligosaccharides, Disaccharides, Monosaccharides and Polyols.Digestion. 2016;94(1):50-6. doi: 10.1159/000448280. Epub 2016 Aug 4. Digestion. 2016. PMID: 27487397 Clinical Trial.
Cited by
-
Intestinal permeability disturbances: causes, diseases and therapy.Clin Exp Med. 2024 Sep 28;24(1):232. doi: 10.1007/s10238-024-01496-9. Clin Exp Med. 2024. PMID: 39340718 Free PMC article. Review.
-
In Vitro Efficacy of Targeted Fermentable Oligosaccharides, Disaccharides, Monosaccharides, and Polyols Enzymatic Digestion in a High-Fidelity Simulated Gastrointestinal Environment.Gastro Hep Adv. 2022 Oct 31;2(3):283-290. doi: 10.1016/j.gastha.2022.10.011. eCollection 2023. Gastro Hep Adv. 2022. PMID: 39132653 Free PMC article.
-
The Role of the FODMAP Diet in IBS.Nutrients. 2024 Jan 26;16(3):370. doi: 10.3390/nu16030370. Nutrients. 2024. PMID: 38337655 Free PMC article. Review.
-
Alterations in gut microbiota caused by major depressive disorder or a low FODMAP diet and where they overlap.Front Nutr. 2024 Jan 8;10:1303405. doi: 10.3389/fnut.2023.1303405. eCollection 2023. Front Nutr. 2024. PMID: 38260072 Free PMC article. Review.
-
Nutraceuticals and biotics in pediatric gastrointestinal disorders.Eur J Clin Nutr. 2024 Feb;78(2):87-98. doi: 10.1038/s41430-023-01362-z. Epub 2023 Oct 24. Eur J Clin Nutr. 2024. PMID: 37875612 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous